filmov
tv
Upfront Systemic Therapy for mCRC
Показать описание
Paul Helft, MD, highlights the use of first-line systemic therapy options for the treatment of metastatic colorectal cancer.
Targeted Oncology
targeted oncology
oncology
cancer
Рекомендации по теме
0:04:42
Upfront Systemic Therapy for mCRC
0:07:58
Choices for Upfront Therapy for mCRC
0:06:44
Deciding on Upfront Treatment for mCRC
0:05:54
Initial Systemic Therapy for Metastatic Colorectal Cancer
0:07:41
Upfront Therapy for Metastatic Colorectal Cancer
0:06:17
Goals of Systemic Therapy in Colorectal Cancer
0:01:43
Areas of Controversy in the Treatment Landscape of mCRC
0:03:58
Dr. Cathy Eng on Bevacizumab Plus FOLFOXIRI for Patients With mCRC
0:05:09
EGFR Therapy as Upfront Colorectal Cancer Treatment
0:05:33
Treatment Options for KRAS-Mutant Unresectable mCRC
0:08:36
Debate: Is there an optimal sequence for first-line therapy in mCRC? - Yes
0:07:43
Therapy in the Salvage Setting of mCRC
0:07:37
Debate: MSI High Colon Cancer - Upfront Chemotherapy
0:14:07
Strategies in Metastatic Colorectal Cancer
0:13:46
Choosing Between VEGF and EGFR Targeted Therapy in mCRC
0:08:17
Multidisciplinary Management of Metastatic Colorectal Cancer
1:00:16
CRCtalks: Liver-Directed Therapies for mCRC
0:08:05
Debate: Is there an optimal sequence for first-line therapy in mCRC? - No
0:59:27
Evolving Multidisciplinary Management of Colorectal Liver Metastases
0:15:47
Management of Adverse Events Associated with Third-line mCRC Treatments
0:21:41
Update 5: Updates in the Management of Rectal Cancer
0:59:25
Webinar on Evolution in mCRC Understanding
0:17:12
CLINICAL CORNER - STIVARGA FOR mCRC
0:03:59
Liver-Directed Therapies in Metastatic Colorectal Cancer